ProVIDE Clinical Study for BPH Treatment – 1st Patient Enrolled

spot_img

Summation

  • ProVerum Limited, an Irish medical device company developing a minimally invasive solution to treat benign prostatic hyperplasia (BPH) in the doctor’s office, today announced the commencement of the ProVIDE pivotal clinical trial to evaluate the safety and effectiveness of the ProVee System, a nitinol expander designed to gently re-shape the enlarged prostate and alleviate the symptoms caused by BPH.
  • The ProVIDE clinical trial is a prospective, multi-center, double-blind controlled study to evaluate the safety, performance, and effectiveness of the ProVee System in patients with lower urinary tract symptoms secondary to BPH.
  •   “This international, multi-center clinical study will thoroughly evaluate the safety, efficacy and long-term durability of the ProVee device and I look forward to presenting the data from this large controlled clinical trial.

ProVerum Limited, an Irish medical device company developing a minimally invasive solution to treat benign prostatic hyperplasia (BPH) in the doctor’s office, today announced the commencement of the ProVIDE pivotal clinical trial to evaluate the safety and effectiveness of the ProVee System, a nitinol expander designed to gently re-shape the enlarged prostate and alleviate the symptoms caused by BPH.

The first procedure was successfully performed by Sijo Parekattil, M.D., Principle Investigator at Avant Concierge Urology, Winter Garden, Florida.

According to Dr Parekattil, “The ProVee procedure is straightforward and comfortably performed in a doctor’s office.”  He continued, “I see many patients whose quality of life are adversely impacted by the symptoms associated with an enlarged prostate and the ProVee System represents an exciting new alternative for BPH treatment.”

Steve Kaplan, M.D., Professor of Urology at the Icahn School of Medicine at Mount Sinai in New York is the Global Lead Investigator for the ProVIDE study. “The ProVee System has the potential to be an effective treatment for BPH that can be safely and reliably performed in the office setting” said Dr. Kaplan.  “This international, multi-center clinical study will thoroughly evaluate the safety, efficacy and long-term durability of the ProVee device and I look forward to presenting the data from this large controlled clinical trial.”

About the ProVIDE Study

The ProVIDE clinical trial is a prospective, multi-center, double-blind controlled study to evaluate the safety, performance, and effectiveness of the ProVee System in patients with lower urinary tract symptoms secondary to BPH.   225 subjects, enrolled across 18 investigational sites in the US and 4 International sites, will be randomized to either receive

The ProVee System or undergo a sham procedure.  After three months, patients will be unblinded and participants who underwent the sham procedure and meet the study inclusion criteria will be eligible to receive treatment with ProVee.  Primary effectiveness will be evaluated using the International Prostate Symptom Score (IPSS) and based on the change from the subject’s baseline measurement to those at three and twelve months.

Articles of Interest

Exploring Wellness Trends in the Multi-Level Marketing (MLM) Industry: A Guide for Health-Conscious Consumers

The Multi-Level Marketing industry is undergoing a profound transformation driven by evolving consumer preferences and technological advancements. For the health-conscious consumer, understanding these trends is essential for making informed choices about wellness products and supplements.

Navigating the World of Crypto Bridges: Top Choices for Seamless Cross-Chain Transactions

Introduction: The decentralized finance (DeFi) ecosystem has witnessed a remarkable surge in popularity, with an...

Comparison of Offshore and Onshore Crypto Licenses

Entrepreneurs who are just starting to think about expanding their crypto business activities and...

What Kind of Equipment is Used to Analyze DNA?

Below are a few basic processes followed throughout DNA testing. The general procedure entails:  •...
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

By using this website you agree to accept Medical Device News Magazine Privacy Policy